Research progress on disialoganglioside as target for immunotherapy of neuroblastoma / 中华实用儿科临床杂志
Chinese Journal of Applied Clinical Pediatrics
;
(24): 1196-1198, 2015.
Artículo
en Chino
| WPRIM
| ID: wpr-480150
ABSTRACT
Neuroblastoma(NB),the common extracranial solid tumor of childhood,is thought to derive from neural crest cells.In disialoganglioside (GD)2 is highly expressed on NB,whereas GD2 expression is weak and restricted to the central nervous system,peripheral pain fibers and skin melanocytes.Therefore,GD2 is an ideal antigen target for immunotherapy of NB.The research progress on GD2 as target for immunotherapy of NB was reviewed.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Applied Clinical Pediatrics
Año:
2015
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS